Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
USD10.67
-0.01 (-0.05%)
US NASDAQ Financial Services Shell Companies
Address
1 East Broward Blvd Suite 700 33301
Fort Lauderdale, FL, US
Fort Lauderdale, FL, US
CEO
Roger Bendelac
Website
dmaacorp.com
IPO
2025-01-27
CIK 2028614 ISIN KYG2847J1040
Also trades on
NASDAQ Global Market · DMAAU (USD)
NASDAQ Global Select · DMAA (USD)
NASDAQ Global Select · DMAAR (USD)
Description
Drugs Made In America Acquisition Corp. functions as a special purpose acquisition company, commonly known as a blank check company. Its core mission is to seek out and ultimately acquire one or more existing businesses or their assets. This acquisition strategy encompasses a variety of transactional methods, such as corporate mergers, capital stock exchanges, direct asset purchases, stock acquisitions, or broader corporate reorganizations.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD10.67
-0.01 (-0.05%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
113.6K
Beta
0.00
Float Shares
27.31M
Free Float %
81.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.09% | +0.00% | +0.76% | +1.43% | +2.71% | +2.31% | +4.74% | +6.53% | +6.53% | +6.53% | +6.53% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Quality scores
Altman Z-Score
28.96
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
2 / 5
Medium
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%+439.3% ★ Q1'26: -99.9% (vs Q1'25)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%-1.2% Q1'26: -0.2% (vs Q1'25)
-
Share dilution Shell Companies: -10.2%+145.1% Q1'26: -9.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×0.00× Q1'26: -0.17× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
39
Total invested
250.70M
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
39
+0 vs prev Q
New positions
6
Closed positions
6
Increased
13
Reduced
7
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | KARPUS MANAGEMENT, INC. | 2.54M -9.0K (-0.4%) | 26.33M +161.2K (+0.6%) | 11.04% +3.437 pp | 0.70% -0.126 pp | USD10.05 +3.2% | 4 qtrs — |
| 2 | FIRST TRUST CAPITAL MANAGEMENT L.P. | 2.24M +— (+0.0%) | 23.26M +233.7K (+1.0%) | 9.75% +3.059 pp | 1.41% -0.077 pp | USD10.03 +3.4% | 4 qtrs — |
| 3 | GLAZER CAPITAL, LLC | 1.82M -5.9K (-0.3%) | 18.84M +121.0K (+0.6%) | 7.90% +2.461 pp | 0.50% -0.133 pp | USD10.02 +3.5% | 4 qtrs — |
| 4 | WESTCHESTER CAPITAL MANAGEMENT, LLC | 1.67M +— (+0.0%) | 17.31M +166.9K (+1.0%) | 7.26% +2.277 pp | 0.73% -0.057 pp | USD10.09 +2.8% | 4 qtrs — |
| 5 | POLAR ASSET MANAGEMENT PARTNERS INC. | 1.60M -300.0K (-15.8%) | 16.60M -2.9M (-14.9%) | 6.96% +1.288 pp | 0.21% -0.008 pp | USD10.02 +3.5% | 4 qtrs — |
| 6 | HUDSON BAY CAPITAL MANAGEMENT LP | 1.55M +— (+0.0%) | 16.07M +155.0K (+1.0%) | 6.74% +2.115 pp | 0.05% +0.000 pp | USD10.02 +3.5% | 4 qtrs — |
| 7 | MIZUHO SECURITIES USA LLC | 1.43M +333.0K (+30.3%) | 14.77M +3.5M (+30.8%) | 6.23% +2.949 pp | 0.24% +0.015 pp | USD10.25 +1.2% | 3 qtrs — |
| 8 | WOLVERINE ASSET MANAGEMENT LLC | 1.31M +58.3K (+4.7%) | 13.56M +735.4K (+5.7%) | 5.68% +1.958 pp | 0.11% +0.012 pp | USD10.14 +2.3% | 4 qtrs — |
| 9 | ARISTEIA CAPITAL LLC | 881.7K +— (+0.0%) | 9.15M +91.9K (+1.0%) | 3.83% +1.203 pp | 0.20% -0.014 pp | USD10.02 +3.5% | 4 qtrs — |
| 10 | MERCURIA CAPITAL STRATEGIES, LLC | 750.0K +750.0K (+100.0%) | 7.51M +7.5M (+100.0%) | 3.26% +3.261 pp | 3.11% +3.108 pp | USD10.37 +0.0% | 1 qtrs NEW |
| 11 | D. E. SHAW & CO., INC. | 690.0K +— (+0.0%) | 7.16M +69.0K (+1.0%) | 3.00% +0.941 pp | 0.00% 0.000 pp | USD10.20 +1.7% | 3 qtrs — |
| 12 | HEIGHTS CAPITAL MANAGEMENT, INC | 650.0K +— (+0.0%) | 6.74M +65.0K (+1.0%) | 2.83% +0.887 pp | 2.42% +0.587 pp | USD10.20 +1.7% | 3 qtrs — |
| 13 | RADCLIFFE CAPITAL MANAGEMENT, L.P. | 546.8K +18.7K (+3.5%) | 5.67M +249.5K (+4.6%) | 2.38% +0.802 pp | 0.31% -0.027 pp | USD10.26 +1.1% | 3 qtrs — |
| 14 | LMR PARTNERS LLP | 500.0K +— (+0.0%) | 5.19M +52.1K (+1.0%) | 2.17% +0.682 pp | 0.01% -0.013 pp | USD10.02 +3.5% | 4 qtrs — |
| 15 | J. GOLDMAN & CO LP | 500.0K +— (+0.0%) | 5.19M +52.1K (+1.0%) | 2.17% +0.682 pp | 0.14% +0.008 pp | USD10.27 +1.0% | 2 qtrs — |
| 16 | RIVERNORTH CAPITAL MANAGEMENT, LLC | 418.0K +100.0K (+31.4%) | 4.33M +1.1M (+32.7%) | 1.82% +0.869 pp | 0.20% +0.019 pp | USD10.29 +0.8% | 2 qtrs — |
| 17 | WHITEBOX ADVISORS LLC | 400.0K +— (+0.0%) | 4.15M +41.7K (+1.0%) | 1.74% +0.546 pp | 0.06% -0.005 pp | USD10.02 +3.5% | 4 qtrs — |
| 18 | AQR ARBITRAGE LLC | 371.2K +— (+0.0%) | 3.85M +37.1K (+1.0%) | 1.61% +0.506 pp | 0.08% -0.016 pp | USD10.02 +3.5% | 4 qtrs — |
| 19 | BOOTHBAY FUND MANAGEMENT, LLC | 346.2K -153.8K (-30.8%) | 3.59M -1.5M (-30.1%) | 1.51% +0.013 pp | 0.05% -0.021 pp | USD10.20 +1.7% | 3 qtrs — |
| 20 | QUARRY LP | 266.6K +250.8K (+1,595.5%) | 2.77M +2.6M (+1,612.8%) | 1.16% +1.112 pp | 0.43% +0.397 pp | USD10.36 +0.1% | 4 qtrs — |
| 21 | GOVERNORS LANE LP | 250.0K +238.8K (+2,132.1%) | 2.59M +2.5M (+2,155.0%) | 1.09% +1.054 pp | 0.15% +0.145 pp | USD10.37 +0.0% | 2 qtrs — |
| 22 | CONTEXT CAPITAL MANAGEMENT, LLC | 250.0K +— (+0.0%) | 2.59M +26.1K (+1.0%) | 1.09% +0.341 pp | 0.07% -0.012 pp | USD10.27 +1.0% | 2 qtrs — |
| 23 | SHAOLIN CAPITAL MANAGEMENT LLC | 202.1K +52.1K (+34.7%) | 2.10M +555.8K (+36.1%) | 0.88% +0.431 pp | 0.06% -0.002 pp | USD10.26 +1.1% | 3 qtrs — |
| 24 | TORONTO DOMINION BANK | 200.0K -250.0K (-55.6%) | 2.07M -2.5M (-55.1%) | 0.87% -0.473 pp | 0.00% -0.004 pp | USD10.02 +3.5% | 4 qtrs — |
| 25 | BULLDOG INVESTORS, LLP | 130.3K +— (+0.0%) | 1.35M +13.0K (+1.0%) | 0.57% +0.178 pp | 0.30% -0.009 pp | USD10.23 +1.4% | 3 qtrs — |
| 26 | GOLDMAN SACHS GROUP INC | 119.7K +— (+0.0%) | 1.24M +12.0K (+1.0%) | 0.52% +0.163 pp | 0.00% +0.000 pp | USD10.02 +3.5% | 4 qtrs — |
| 27 | DLD ASSET MANAGEMENT, LP | 100.6K -13.1K (-11.5%) | 1.04M -124.2K (-10.6%) | 0.44% +0.098 pp | 0.08% +0.016 pp | USD10.02 +3.5% | 4 qtrs — |
| 28 | CLEAR STREET GROUP INC. | 326.0K +116.4K (+55.5%) | 995.6K -1.2M (-53.7%) | 1.42% +0.792 pp | 0.00% -0.004 pp | USD10.31 +0.6% | 2 qtrs — |
| 29 | WARBERG ASSET MANAGEMENT LLC | 92.1K +— (+0.0%) | 955.1K +9.7K (+1.0%) | 0.40% +0.126 pp | 0.11% -0.036 pp | USD10.02 +3.5% | 4 qtrs — |
| 30 | PERISCOPE CAPITAL INC. | 50.0K +— (+0.0%) | 518.8K +5.3K (+1.0%) | 0.22% +0.068 pp | 0.06% -0.022 pp | USD10.27 +1.0% | 2 qtrs — |
| 31 | JPMORGAN CHASE & CO | 49.8K -49.9K (-50.0%) | 516.6K -507.2K (-49.5%) | 0.22% -0.081 pp | 0.00% +0.000 pp | USD10.27 +1.0% | 2 qtrs — |
| 32 | GEODE CAPITAL MANAGEMENT, LLC | 45.6K +— (+0.0%) | 473.4K +4.6K (+1.0%) | 0.20% +0.062 pp | 0.00% +0.000 pp | USD10.02 +3.5% | 4 qtrs — |
| 33 | UBS GROUP AG | 38.2K +18.0K (+89.6%) | 395.7K +189.1K (+91.5%) | 0.17% +0.106 pp | 0.00% +0.000 pp | USD10.32 +0.5% | 3 qtrs — |
| 34 | DAKOTA WEALTH MANAGEMENT | 36.4K +— (+0.0%) | 377.5K +3.6K (+1.0%) | 0.16% +0.050 pp | 0.01% -0.001 pp | USD10.27 +1.0% | 2 qtrs — |
| 35 | — | 31.8K +31.8K (+100.0%) | 330.3K +330.3K (+100.0%) | 0.14% +0.138 pp | 0.12% +0.124 pp | USD10.37 +0.0% | 1 qtrs NEW |
| 36 | HRT FINANCIAL LP | 28.3K +795.0 (+2.9%) | 293.0K +11.0K (+3.9%) | 0.12% +0.041 pp | 0.00% 0.000 pp | USD10.27 +1.0% | 2 qtrs — |
| 37 | LOGAN STONE CAPITAL, LLC | 10.9K +10.9K (+100.0%) | 113.1K +113.1K (+100.0%) | 0.05% +0.047 pp | 0.03% +0.028 pp | USD10.37 +0.0% | 3 qtrs — |
| 38 | MORGAN STANLEY | 121.00 +89.0 (+278.1%) | 1.3K +926.0 (+281.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD10.30 +0.7% | 4 qtrs — |
| 39 | SANDIA INVESTMENT MANAGEMENT LP | — -15.7K (-100.0%) | — -161.5K (-100.0%) | 0.00% -0.047 pp | 0.00% -0.481 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
3.00
Bullish
Ratio by volume
0.17
Bearish
Buys
12
Sells
4
Shares acquired
2.12M
Shares disposed
12.20M
Cash buys
8.00
Cash sales
2.00
Net activity
-10,076,726
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | Stockwell Lynn | Director / Officer / 10% Owner | P-Purchase | A | Ordinary shares | 30,000 | 0.00 | — | 4,188,780 | I | ↗ |
| 2025-02-18 | Drugs Made In America Acquisition LLC | 10% Owner | P-Purchase | A | Ordinary shares | 30,000 | 0.00 | — | 4,188,780 | D | ↗ |
| 2025-01-29 | Worman Glenn C. | Officer | J-Other | A | Ordinary shares | 100,000 | 0.00 | — | 100,000 | D | ↗ |
| 2025-01-29 | Stockwell Lynn | Director / Officer / 10% Owner | S-Sale | D | Ordinary shares | 5,698,363 | 1.50 | 8.55M | 4,158,780 | I | ↗ |
| 2025-01-29 | Shulgan Myron W. | Director | J-Other | A | Ordinary shares | 100,000 | 0.00 | — | 100,000 | D | ↗ |
| 2025-01-29 | Prasad Sridhar G. | Director | J-Other | A | Ordinary shares | 100,000 | 0.00 | — | 100,000 | D | ↗ |
| 2025-01-29 | Drugs Made In America Acquisition LLC | 10% Owner | P-Purchase | A | Ordinary shares | 400,000 | 0.00 | — | 10,257,143 | D | ↗ |
| 2025-01-29 | Do Catherine | Director | J-Other | A | Ordinary shares | 100,000 | 0.00 | — | 100,000 | D | ↗ |
| 2025-01-07 | Worman Glenn C. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-07 | Stockwell Lynn | Director / Officer / 10% Owner | — | — | Ordinary Shares | 0 | 0.00 | — | 9,857,143 | I | ↗ |
| 2025-01-07 | Shulgan Myron W. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-07 | Prasad Sridhar G. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-07 | Drugs Made In America Acquisition LLC | 10% Owner | — | — | Ordinary Shares | 0 | 0.00 | — | 9,857,143 | D | ↗ |
| 2025-01-07 | Do Catherine | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
33.72M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Roger Bendelac | Chief Executive Officer | — | male |
| Saleem Elmasri | CFO & Principal Accounting Officer | — | male |
ESG Rating
ESG Score History
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DMAA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
